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SUMMARY
Cutaneous leishmaniasis caused by various species of Leishmania is a signiﬁcant zoonotic disease
in many parts of the world. We describe the ﬁrst cases of Australian cutaneous leishmaniasis
in eight northern wallaroos, one black wallaroo and two agile wallabies from the Northern
Territory of Australia. Diagnosis was made through a combination of gross appearance of
lesions, cytology, histology, direct culture, serology and a species-speciﬁc real-time PCR. The
causative organism was found to be the same unique species of Leishmania previously identiﬁed
in red kangaroos. These clinical ﬁndings provide further evidence for the continuous transmission
of the Australian Leishmania species and its presence highlights the importance of continued
monitoring and research into the life-cycle of this parasite.
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The Leishmania spp. are protozoan parasites which
naturally infect many diﬀerent species of mammal
worldwide. They are the causative agent for zoonotic
disease and the most common form, cutaneous leish-
maniasis (CL), is believed to aﬀect some 1–1.5 million
people every year, with a further 350 million at risk of
infection. A potentially fatal form known as visceral
leishmaniasis (VL) aﬀects another 500 000 people
anually. Those aﬀected are predominantly from poor
or marginalized countries and it is widely believed
that disease prevalence is grossly underestimated. The
Leishmania parasite has a dimorphic life-cycle, being
able to exist either intracellularly in the macrophages
of its mammalian host or extracellularly within the
gut of a phlebotomine sand-ﬂy vector [1].
The ﬁrst report of CL in Australia was published in
2004 [2]. Until this report Australia and Antarctica
were the only continents considered free of Leish-
mania parasites. The Australian cases of CL were di-
agnosed in captive red kangaroos (Macropus rufus)
and restricted to the rural Darwin area of the North-
ern Territory (NT). Red kangaroos are widespread
across much of inland Australia but they are not na-
tive to the more humid northern tropical regions and
the disease was seen as an opportunistic infection. The
causative species was characterized as a unique spe-
cies of Leishmania likely to be endemic to Australia.
We now report the ﬁrst Australian clinical cases of CL
in three other captive species, i.e. northern wallaroo
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(Macropus robustus woodwardi), black wallaroo
(M. bernardus) and agile wallaby (M. agilis agilis).
Skin lesions suggestive of CL were observed in eight
captive northern wallaroos housed together in a
monsoonal open woodland habitat at a facility in the
rural Darwin area in the NT of Australia. The wal-
laroos had been in captivity for 9 years before show-
ing clinical signs of CL which have been ongoing
since. Northern wallaroos are macropods native to
the tropical regions of the NT and northeastern
Western Australia. Their natural habitat is typically
associated with drier rocky escarpment and hilly
country [3]. The lesions were located distally in
areas concentrated on the tail, inner forearms, hind
legs and ears. Grossly, lesions on the limbs and tail
appeared as focal to coalescing 0.5–2 cm diameter
areas of thickened skin or raised variably encrusted
or ulcerative pale nodules (Fig. 1). On ears, lesions
involved primarily the distal margins of the pinnae
which were irregular in outline, were mildly swollen
and variably encrusted. The severity and number
of lesions varied in the aﬀected individuals. In-
terestingly, lesions in two animals were observed
on the cloaca, evidence of possible mucosal in-
fection. For the index case, amastigotes were seen
by microscopic examination of Diﬀ-Quik (Lab Aids
Pty Ltd, Australia)-stained impression smears of
lesions (Fig. 1). Histological examination of the af-
fected skin from the index northern wallaroo case
was prepared in standard fashion and 5-mm-thick
sections were stained with haematoxylin and eosin.
Lesions were characterized by moderate to marked
inﬁltration of the superﬁcial and/or deep dermis
with macrophages containing abundant amastigotes.
There were moderate numbers of plasma cells and
lymphocytes intermingled with macrophages pres-
ent in the dermis and at the margins of lesions
(Fig. 1).
The diagnosis in this case and a further three
cases was conﬁrmed by direct culture from the tissue
of various lesions or swollen ear margins using stan-
dard Leishmania culture in NNN medium [2]. DNA
extraction was carried out from various skin lesions,
spleen, lymph nodes or cloaca using a commercially
available kit (DNeasy Tissue kit, Qiagen Ltd,
Australia) according to the manufacturer’s instruc-
tions. These tissue samples were analysed by a
Taqman probe species-speciﬁc real-time PCR target-
ing the mini-exon gene from the kangaroo Leish-
mania [2]. Reactions were carried out using 1r
InvitrogenTM Platinum1 Quantitative PCR Super-
Mix-UDG (Invitrogen, Australia) using 0.3 mM of
(a) (b) (c)
Fig. 1. (a) Medial hock of a northern wallaroo depicting multiple smooth nodules (arrows) and one ulcerated and encrusted
lesion (arrowhead) (scale bar, 1 cm). (b) Impression smear from a northern wallaroo skin lesion depicting four infected
macrophages among lymphocytes and cellular debris. Arrows point to three individual Leishmania amastigotes, each with
round dark nucleus and single kidney kinetoplast. Diﬀ-quik stain (Lab Aids Pty Ltd) (scale bar, 10 mm). (c) Histological
section of skin lesion from a northern wallaroo depicting marked deep dermal inﬁltration with macrophages resulting in
expansion of the dermis and obliteration of normal dermal structures in the lower right portion of the panel. The inﬁltrate
wanes towards the left upper region of the panel, where the dermis is moderately inﬁltrated with primarily lymphocytes and
plasma cells. Haematoxylin and eosin stain (scale bar, 200 mm).
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primers rooME-F2 5k-AAACTTCCGGAACCTG-
TCGT-3k and rooME-R2 5k-GTAGGCACCCGA-
AGAGACC-3k and 0.05 mM Taqman probe 5k-d
FAM-CCGGCAAGATTTTGGGAGCG-BHQ-1-3k
(Biosearch Technologies Inc., USA). MgCl2 was used
at the ﬁnal concentration of 6 mM with the addition of
1r Q solution (Qiagen Ltd). Cycling and ﬂuorescent
detection was 2 min at 50 xC, 2 min at 95 xC followed
by 35 cycles : 15 s at 95 xC and 40 s at 60 xC acquiring
to cycling A Green using the Rotor gene 2000 or 6000
(Corbett Life Science, Australia). All skin lesion tissue
sampled from six cases including the four cases from
which the organism was cultured, were positive using
this real-time PCR. Lymph node was positive from
2/2 samples and spleen tissue was positive in 1/2
samples. One animal with lesions seen on the cloaca
was positive for real-time PCR by NNN medium
culture using tissue taken directly from this region
conﬁrming a mucosal infection.
Sera collected from 7/8 cases were also posi-
tive using an enzyme-linked immunosorbent assay
(ELISA). This assay demonstrated speciﬁc IgG anti-
bodies to soluble Leishmania antigen (SLA) prepared
using cultured promastigotes from northern wallaroo
lesions. SLA was prepared by washing cultures three
times with 1r PBS; 1r108/ml of promastigotes were
then freeze-thawed ﬁve times. For ELISA the soluble
antigen was applied for 2 h at 37 xC using a 1/100
dilution in carbonate buﬀer (pH 9.6) to a 96-well
plate. The SLA was blocked with 3% BSA/0.05%
Tween-20 and serum was applied at a 1/600 dilution.
Bound serum IgG was then detected using a 1/2000
dilution of pProtein A conjugated to horseradish
peroxidise (Sigma-Aldrich Pty Ltd, Australia).
Binding was detected using 3,3k,5,5k-tetramethyl-
benzidine substrate for ELISA (Sigma-Aldrich Pty
Ltd). Opportunistic tissue or blood collection was not
possible for one case although the symptoms were
consistent with those seen in the other animals.
Molecular diversity was investigated in two cases
using PCR ampliﬁcation and ﬂuorescent sequencing
with published primers for the Leishmania mini-
exon gene [4]. Results conﬁrmed sequence match
with the original Leishmania sp. from red kanga-
roos [2].
In addition we report for the ﬁrst time Australian
CL in one black wallaroo and two agile wallabies
housed in separate enclosures at the same facility.
These enclosures were within 2 km of those housing
the northern wallaroos with CL as well as the pre-
viously documented red kangaroos [2]. In the black
wallaroo and agile wallabies symptoms of CL were
seen about 6 months after an initial investigation for
disease in the northern wallaroos. As with the north-
ern wallaroos, the black wallaroo had been in cap-
tivity for some years before showing clinical signs
of CL. In the wild its range is restricted to steep rocky
escarpment and plateau country of west and central
Arnhem Land in the NT. The captive environment
is open monsoonal woodland with agile wallabies
naturally abundant in the area. The black wallaroo
exhibited lesions on the ears similar to the appearance
in the northern wallaroos. It also had small nodular
lesions around the eyes, again indicating possible
mucosal involvement of the parasite. The IgG re-
sponse was positive to SLA and ear tissue was positive
by species-speciﬁc real-time PCR. The two agile
wallabies showed less severe symptoms with lesions
appearing predominantly on the ears. Ear tissue
for both animals was positive using species-speciﬁc
real-time PCR and they showed high serological re-
sponses to SLA. Agile wallabies are the most common
macropod species in the Darwin rural area and are
abundant in the bush surroundings of the captive
facility. They have a gregarious nature and are easily
maintained in captivity and on public display. The
two agile wallaby cases were juveniles recently in-
troduced to the captive environment, thus it may have
been their ﬁrst exposure to Leishmania. Lesions have
subsequently healed for the agile wallabies involved
in this study. This suggests an inherent immunity
in these animals. Further epidemiological studies are
needed to establish their possible role as reservoirs of
Australian Leishmania.
Naivety to infection and subclinical stress related to
an incompatibility with their captive conditions may
have contributed to the varying severity of disease
seen in all of the macropod species described here.
The monsoonal open woodland environment in which
the animals were housed is not typical for northern
wallaroos or black wallaroos. They tend to be solitary
and secretive in nature and are also known to be an-
xious in captivity and wary of exposure to the public.
There have been no reports of CL in wild populations
of northern wallaroos, black wallaroos or agile wal-
labies. CL seen in these captive macropods some
years after the ﬁrst report of CL in Australia suggests
that Leishmania is endemic to the tropical region of
the NT. Moreover CL previously seen in red kangar-
oos was seen in two separate locations>20 km apart
also indicating transmission across the Darwin rural
area [2].
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The phlebotomine sand-ﬂy vector and the natural
reservoir host are yet to be identiﬁed. Phlebotomine
sand-ﬂies from the Old World genera Phlebotomus
and Sergentomyia are present in Australia, but little is
known about their capacity as vectors of Leishmania
spp. We hypothesize that one or more native species
of macropod common to the Darwin rural area are
natural reservoir hosts for Australian Leishmania.
Sera and ear tissue collected from agile wallabies and
antilopine wallaroos (M. antilopinis) in the region are
currently being surveyed by ELISA and real-time
PCR for evidence of Leishmania infection. Further
research is vital in determining the reservoir status of
these animals and other native marsupials found in
the tropical north of Australia.
To date, no human cases of CL caused by the
Australian species of Leishmania have been reported.
Phlebotomine sand-ﬂies of Australia are not known
to bite humans so transmission is an unlikely event,
although the vector of Leishmania in Australia is still
unknown [5]. However, leishmaniasis in travellers and
migrants who have travelled through or resided in
endemic countries does occur in Australia. The
Women’s and Children’s Hospital in Adelaide, South
Australia, reported CL in Afghani refugees who had
been in Australia up to 5 months before receiving
treatment [6]. Royal Darwin Hospital in the NT
treated a patient for CL caused by L. braziliensis
who had been travelling for 1 year through South
America [7]. In addition, the Darwin region has
recently seen an increase in the number of refugees
arriving from Sudan, a country that is endemic for
VL. Darwin is also home to a number of Australian
Defence Force personnel and CL has been observed
in some soldiers returning from war zones such as
Iraq and Afghanistan. Furthermore, in November
1999, 46 cases of CL were reported from in East
Timor [8], which is only 640 km northwest of Darwin.
The causative Leishmania sp. was undetermined.
VL in dogs could be another source for the intro-
duction of an exotic Leishmania sp. into Australia.
Currently all dogs are required to have a negative
result for leishmaniasis prior to importation into
Australia. The dogs are screened within 30 days prior
to export by an indirect ﬂuorescent antibody test
(IFAT), or ELISA, as described in the Oﬃce Inter-
national des Epizooties Manual [9]. Although the
likelihood for an exotic introduction through im-
ported dogs is low, consideration should be made for
false-negative results which can occur using these
tests. Leontides et al. surveyed 73 dogs from Greece
for Leishmania spp. infection and found 63% positive
by a bone marrow PCR, with only 12.3% being
positive by IFAT. Dogs can carry the Leishmania
parasite for months before there are signs of sero-
conversion [10].
This report of CL in northern wallaroos, a black
wallaroo and agile wallabies highlights the import-
ance of continued research into the life-cycle of
Leishmania in Australia. It also demonstrates that ‘as
yet undetermined’ Leishmania-transmitting vectors
are endemic in Australia. The introduction of an
exotic parasite into Australia, although seemingly
unlikely, could have signiﬁcant eﬀects on native
wildlife, livestock and public health.
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